ClinVar Miner

Submissions for variant NM_001101.5(ACTB):c.7_8delinsTT (p.Asp3Phe)

dbSNP: rs1784841235
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001243702 SCV001416876 likely pathogenic Baraitser-Winter syndrome 1 2019-08-07 criteria provided, single submitter clinical testing This sequence change replaces aspartic acid with phenylalanine at codon 3 of the ACTB protein (p.Asp3Phe). The aspartic acid residue is moderately conserved and there is a large physicochemical difference between aspartic acid and phenylalanine. This variant is not present in population databases (ExAC no frequency). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). This variant has been observed to be de novo in an individual with clinical features of Baraitser-Winter syndrome (Invitae).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.